CPD Portal
Gla-300 Vs IDeg-100: What the first RCT says
MEDICAL CHRONICLE OCTOBER CPD 3 of 4: The BRIGHT study results reflect positively on these second-generation longer-acting basal insulin analogues, both of which reduced HbA1c, glucose profiles and fasting SMPG.
How to combat statin-associated muscle symptoms
MEDICAL CHRONICLE OCTOBER CPD 4 of 4: Despite some potentially severe side effects, statins are possibly the most effective drugs for the prevention and treatment of hypercholesterolemia and coronary heart disease.
Vitamin B deficiency in patients with diabetes
SPECIALIST FORUM AUGUST CPD 1 of 4: Vitamins are actively involved in many metabolic processes of the nervous system. Their deficit may cause severe and, sometimes, irreversible consequences for diabetic patients.
Using dressings to manage pain in diabetic foot ulcers
Proper management of diabetic foot ulcers is an essential but often overlooked component of diabetic wound care. Wound dressing technology is constantly advancing and there is no reason why diabetics should suffer complications resulting from ulceration or even amputation as a result of their condition.
What is new about SGLT-2 inhibitors?
MEDICAL CHRONICLE JULY 2018: CPD 3 of 5
New insulin reduces nocturnal hypoglycaemia
Sanofi is the first company in South African medical history to introduce a newly launched product available at the cost of a clone.
That sugar high
In January 2018 the American Diabetes Association (ADA) updated their Standards of Medical Care for the treatment of type 1 diabetes and diabetes mellitus type 2 (DMT2).
Safety, efficacy of Biosimilar human insulins
Diabetes mellitus (diabetes) affects people worldwide and poses major public health and socio-economic challenges. The disorder was previously thought to be rare or undocumented in rural Africa, but over the past few decades it has emerged as an important non-communicable disease (NCD) in sub-Saharan Africa (SSA).
Achieving glycaemic control
Diabetes is South Africa’s second biggest killer but there is a critical lack of consensus among experts and policymakers about how this growing epidemic should be tackled.
A new era in the management of type 2 Diabetes
Various studies have thrust the sodium glucose cotransporter 2 (SGLT2) inhibitors (‘gliflozin’) into the forefront of T2DM guidelines.
Managing a monster
Diabetes is a life-long disease that affects the way the body handles glucose, a sugar in the blood. Most people with the condition have type 2. Type 2 diabetes has been increasing substantially over the last 20 years.
Importance of adherence to treatment
SMART diabetes care
Diabetes has become a leading cause of death worldwide. Although there is no cure for diabetes, blood glucose monitoring combined with appropriate medication can enhance treatment efficiency, alleviate the symptoms, as well as diminish complications.
